IV
Invesco Ltd.
IVZ · NYSE
$30.08 -2.29% (-$0.71)
1M -4.94%
Market Cap $13.3B
P/E Ratio -
Div. Yield 2.83%
ROE 0.51%
Bulios Fair Price
$37.56
24.9% upside
Current Price
$30.08
Undervalued Fair Value Overvalued
According to Bulios Fair Price, IVZ is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
98 /100
Cheap P/S 1.93x
P/B 1.07x
P/E N/A
Growth
15 /100
Declining Rev. growth 1.78%
Book val. growth 7.02%
EPS growth N/A
Profitability
0 /100
Weak Net margin 0.93%
Op. margin 7.10%
Gross margin N/A
Quality
15 /100
Poor ROE 0.51%
ROA 0.23%
Asset turnover 0.25x
Debt
39 /100
Moderate Current ratio 0.71x
Debt/Equity N/A
Int. coverage N/A
Stability
41 /100
Moderate Beta 1.61x
Rev. volatility 6.44%
EPS volatility 265.63%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IVZ
Online
Sector
Financial Services
Industry
Asset Management
CEO
Andrew Ryan Schlossberg
Employees
7,405
Headquarters
Atlanta
Upcoming events
27 OCT
Earnings
Upcoming earnings report